Cover Image

Tratamiento de tuberculosis MDR / XDR en Perú. ¿Vamos por buen camino?

Saved in:

Bibliographic Details
Main Author:	Samuel Pecho-Silva (Author)
Format:	Book
Published:	Universidad Nacional Hermilio Valdizán, 2020-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antibióticos como promotores del crecimiento en animales: ¿Vamos por el buen camino?
by: Torres Carmen, et al.
Published: (2002)

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
by: Luigi R. Codecasa, et al.
Published: (2017)

Antibióticos como promotores del crecimiento en animales: ¿Vamos por el buen camino? Antibiotics as growth promoters in animals: Are we going down the right road?
by: Carmen Torres, et al.
Published: (2002)

REC: Interventional Cardiology: en el buen camino
by: José M. de la Torre-Hernández, et al.
Published: (2022)

Global trends in the incidence rates of MDR and XDR tuberculosis: Findings from the global burden of disease study 2019
by: Qingting Bu, et al.
Published: (2023)

Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Chinese Patients With MDR and XDR Nosocomial Pneumonia
by: Huihui Zeng, et al.
Published: (2021)

Age of Antibiotic Resistance in MDR/XDR Clinical Pathogen of <i>Pseudomonas aeruginosa</i>
by: Ashish Kothari, et al.
Published: (2023)

¡Buen Camino! El Camino de Santiago como recurso didáctico en la enseñanza de E/LE
by: Inmaculada Barbasán Ortuño, et al.
Published: (2013)

¡Buen Camino! El Camino de Santiago como recurso didáctico en la enseñanza de E/LE
by: Inmaculada Barbasán Ortuño, et al.
Published: (2013)

Impact of Whole-Genome Sequencing of <i>Mycobacterium tuberculosis</i> on Treatment Outcomes for MDR-TB/XDR-TB: A Systematic Review
by: Druti Hazra, et al.
Published: (2023)

Elucidating the efficacy of combination therapy and colistin resistance mechanisms in MDR/XDR Gram-negative Bacilli
by: Diana Abdulghani, et al.
Published: (2020)

XDR tuberculosis: A looming threat
by: Sharma Vishal, et al.
Published: (2009)

Vamos a florecer los caminos, estéticas y estados modificados de conciencia (EMC)
by: Jorge Echeverri González
Published: (2003)

Clinical Characteristics and Outcome of MDR/XDR Bacterial Infections in a Neuromuscular Semi-Intensive/Sub-Intensive Care Unit
by: Arta Karruli, et al.
Published: (2022)

COLISTINA EN EL TRATAMIENTO DE INFECCIONES POR PSEUDOMONAS AERUGINOSA Y ACINETOBACTER BAUMANNII EXTENSIVAMENTE RESISTENTES (XDR) EN UN HOSPITAL DE TERCER NIVEL
by: Eddie Angles-Yanqui
Published: (2020)

La caravana "Vamos a andar por los caminos de la Historia." una alternativa para el desarrollo del trabajo comunitario en la comunidad montañosa Guamuhaya
by: Agnie Sánchez Acosta, et al.
Published: (2007)

First report of extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) infection in Kuwait
by: Eiman Mokaddas, et al.
Published: (2021)

Transmission Electron Microscopy of XDR Mycobacterium tuberculosis Isolates Grown on High Dose of Oﬂoxacin
by: Mohammad Arjomandzadegan, et al.
Published: (2017)

La Demanda por un Buen Trato en la Escuela Secundaria
by: Veronica Soledad Silva
Published: (2018)

El Buen Vivir, camino del Movimiento Mundial de Salud de los Pueblos Latinoamérica hacia otra alternativa al desarrollo
by: Marcela Beatriz Bobatto, et al.
Published: (2020)

Multi-drug resistant (MDR) and extensively drug-resistant (XDR) bacteraemia rates among cancer patients in an oncology hospital in eastern India: an 11-year retrospective observational study
by: Satyam Mukherjee, et al.
Published: (2023)

Debate - TB or XDR TB, should that be the question?
by: Andrew Black
Published: (2007)

The effects of tuberculosis treatment on the function of the liver of XDR-TB patients with accompanying viral hepatitis (B and C).
by: Агигат Кадырова, et al.
Published: (2019)

COVID-19 y la "locura" por la ivermectina
by: Samuel Pecho-Silva
Published: (2020)

Vamos cuidar com brinquedos?
by: Lígia Mara Dolce Lemos, et al.

Vamos cuidar com brinquedos?
by: Lígia Mara Dolce Lemos, et al.
Published: (2010)

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
by: Monadil H. Ali, et al.
Published: (2019)

Ni vamos a por todas ni tiramos la toalla
by: Lucía Navarro-Marchena, et al.
Published: (2020)

Successful treatment of multi-focal XDR tuberculous osteomyelitis
by: Abeer N. Alshukairi, et al.
Published: (2016)

Safety and effectiveness of all-oral and injectable-containing, bedaquiline-based long treatment regimen for pre-XDR tuberculosis in Vietnam
by: Thi Mai Phuong Nguyen, et al.
Published: (2022)

Voluntades anticipadas en nefrología, ¿vamos con retraso?
by: Miguel Nuñez Moral
Published: (2018)

Disadvantage and the experience of treatment for multidrug-resistant tuberculosis (MDR-TB)
by: Holly A. Taylor, et al.
Published: (2022)

Southern Africa is moving swiftly to combat the threat of XDR-TB
by: Jacqui Wise
Published: (2006)

Por el camino de la excelencia
by: RICARDO RODRÍGUEZ LLANES, et al.

Por el camino de la excelencia
by: Ricardo Rodríguez Llanes, et al.
Published: (2015)

INFECCION POR LISTERIA MONOCYTOGENES Y EMBARAZO CON BUEN RESULTADO PERINATAL
by: Ariel Cisternas V., et al.
Published: (2002)

Combined Resistance to Ceftolozane-Tazobactam and Ceftazidime-Avibactam in Extensively Drug-Resistant (XDR) and Multidrug-Resistant (MDR) <i>Pseudomonas aeruginosa</i>: Resistance Predictors and Impact on Clinical Outcomes Besides Implications for Antimicrobial Stewardship Programs
by: Marianna Meschiari, et al.
Published: (2021)

Vamos a cambiar el mundo
by: María Isabel Cortijo Delgado, et al.
Published: (2013)

Vamos a cambiar el mundo
by: María Isabel Cortijo Delgado, et al.
Published: (2013)

Resistencia a isoniacida, un problema de salud pública: historia y tratamiento
by: Samuel Pecho-Silva, et al.
Published: (2019)